Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial
- Synchron CEO Tom Oxley announced the launch of a BCI registry for users and physicians.
- The registry aims to facilitate engagement and connection for potential users in preparation for clinical trials.
- The CEO expressed excitement for the growth of a grassroots BCI movement.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left1Leaning Right1Center4Last Updated23 days agoBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
66% Center
L 17%
C 66%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage